Disclosure as per Regulation 7 (2) of SEBI (PIT) Regulations, 2015
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Aptus Pharma Ltd received Form C disclosures from 11 promoter group members reporting off-market inter-se transfers between 11-13 May 2026. Total volume of shares moved was 4,20,000 equity shares with an approximate total transaction value of ₹14.7 crore (at ~₹350/share). Most transfers involved 18,000 shares (acquisition by Thakker, Pansuriya, Tanna, Lalseta, Unadkat, Kripaliben Thakker) and 10,000 shares (acquisition by Chandarana, Tejasbhai Hathi). One sale was reported — Chatrabhujbhai Butani sold 1,24,000 shares, reducing his holding from 3.28% to 1.47%. All transactions were off-market inter-se transfers among promoter group members, reported on BSE.
The transactions represent internal reshuffling of promoter holdings with no net change in total promoter stake. No impact on free float or public shareholder structure. Off-market nature indicates private arrangement within promoter family/group rather than market sentiment signal.